Northwest Biotherapeutics Inc’s Q3 2026 10-Q window runs Nov 6, 2026 to Nov 17, 2026.
Based on 8 prior 10-Q filings.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR